Ventyx Biosciences Statistics
Share Statistics
Ventyx Biosciences has 71.16M
shares outstanding. The number of shares has increased by 0.89%
in one year.
| Shares Outstanding | 71.16M |
| Shares Change (YoY) | 0.89% |
| Shares Change (QoQ) | 0.59% |
| Owned by Institutions (%) | 77.05% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 182,062 |
| FTD / Avg. Volume | 15.87% |
Short Selling Information
The latest short interest is 7.22M, so 10.15% of the outstanding
shares have been sold short.
| Short Interest | 7.22M |
| Short % of Shares Out | 10.15% |
| Short % of Float | 10.78% |
| Short Ratio (days to cover) | 8.54 |
Valuation Ratios
The PE ratio is -1.11 and the forward
PE ratio is -0.94.
Ventyx Biosciences's PEG ratio is
0.03.
| PE Ratio | -1.11 |
| Forward PE | -0.94 |
| PS Ratio | 0 |
| Forward PS | 0.4 |
| PB Ratio | 0.59 |
| P/FCF Ratio | -1.14 |
| PEG Ratio | 0.03 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Ventyx Biosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.97,
with a Debt / Equity ratio of 0.04.
| Current Ratio | 17.97 |
| Quick Ratio | 17.97 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | -0.08 |
| Debt / FCF | -0.08 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,668,172.84 |
| Employee Count | 81 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -61.56% in the
last 52 weeks. The beta is 0.73, so Ventyx Biosciences's
price volatility has been higher than the market average.
| Beta | 0.73 |
| 52-Week Price Change | -61.56% |
| 50-Day Moving Average | 1.24 |
| 200-Day Moving Average | 1.88 |
| Relative Strength Index (RSI) | 65.35 |
| Average Volume (20 Days) | 1,147,131 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -148.45M |
| Net Income | -135.12M |
| EBITDA | -133.77M |
| EBIT | -135.12M |
| Earnings Per Share (EPS) | -1.97 |
Full Income StatementBalance Sheet
The company has 27.26M in cash and 10.79M in
debt, giving a net cash position of 16.47M.
| Cash & Cash Equivalents | 27.26M |
| Total Debt | 10.79M |
| Net Cash | 16.47M |
| Retained Earnings | -554.31M |
| Total Assets | 253.48M |
| Working Capital | 230.16M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -130.87M
and capital expenditures -241K, giving a free cash flow of -131.11M.
| Operating Cash Flow | -130.87M |
| Capital Expenditures | -241K |
| Free Cash Flow | -131.11M |
| FCF Per Share | -1.91 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
